Additionally, the increased expression of CX3CR1 in NK cells of the early-stage MMD group suggests enhanced adhesion and chemotaxis capabilities, indicating a more active role of NK cells in inflammation and immune responses in early-stage MMD patients. The gene discussed is CX3CR1; the disease is multiminicore myopathy.